Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial: a rebuttal

J Thromb Haemost. 2012 Mar;10(3):500-2; author reply 502-4. doi: 10.1111/j.1538-7836.2011.04579.x.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Atrial Fibrillation / drug therapy*
  • Benzimidazoles / pharmacokinetics*
  • Humans
  • Pyridines / pharmacokinetics*
  • Thrombin / antagonists & inhibitors*

Substances

  • Benzimidazoles
  • Pyridines
  • Thrombin